Inhaltsbereich
| 121 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
 Druckansicht
|
| Activity of T-DM1 in Her2-positive breast cancer brain metastases. |
| Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, Dieckmann K, Pinker K, Bago-Horvath Z, Galid A, Oehler L, Zielinski CC, Gnant M, Steger GG, Preusser M |
| Clinical & experimental metastasis. 2015 Aug 25. doi: 10.1007/s10585-015-9740-3 |
| PMID: 26303828 |
| Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. |
| Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R |
| Clinical breast cancer. 2015 Jun 18. pii: S1526-8209(15)00123-8. doi: 10.1016/j.clbc.2015.06.007 |
| PMID: 26195436 |
| Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T. |
| Magometschnigg HF, Baltzer PA, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K |
| European journal of nuclear medicine and molecular imaging. 2015 Jun 30. doi: 10.1007/s00259-015-3099-1 |
| PMID: 26121928 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
| Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| PMID: 26040499 |
| Reply to the letter to the editor 'Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients' by Fouad et al. |
| Gnant M, Dubsky PC |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 4. pii: mdv218. doi: 10.1093/annonc/mdv218 |
| PMID: 25939895 |
| Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype. |
| Gnant M, Sestak I, Filipits M, Dowsett M, Balic M, Lopez-Knowles E, Greil R, Dubsky P, Stoeger H, Rudas M, Jakesz R, Ferree S, Cowens JW, Nielsen T, Schaper C, Fesl C, Cuzick J |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 1. pii: mdv215. doi: 10.1093/annonc/mdv215 |
| PMID: 25935792 |
| The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial. |
| Fitzal F, Filipits M, Rudas M, Greil R, Dietze O, Samonigg H, Lax S, Herz W, Dubsky P, Bartsch R, Kronenwett R, Gnant M |
| British journal of cancer. 2015 Mar 24. pii: bjc201598. doi: 10.1038/bjc.2015.98. pmc: PMC4402462 |
| PMID: 25867274 |
| Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer. |
| Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R |
| Breast care (Basel, Switzerland). 2015 Mar 11. doi: 10.1159/000368330. pii: brc-0009-0344. pmc: PMC4322687 |
| PMID: 25759615 |
| Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study. |
| Pinker K, Baltzer P, Bogner W, Leithner D, Trattnig S, Zaric O, Dubsky P, Bago-Horvath Z, Rudas M, Gruber S, Weber M, Helbich TH |
| Radiology. 2015 Mar 4. doi: 10.1148/radiol.15141905 |
| PMID: 25751227 |
| Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development. |
| Stahel R, Bogaerts J, Ciardiello F, de Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart M, Smit E, Sotiriou C, Tejpar S, Van Cutsem E, Tabernero J |
| Cancer treatment reviews. 2014 Dec 16. pii: S0305-7372(14)00209-6. doi: 10.1016/j.ctrv.2014.12.004 |
| PMID: 25533737 |
| Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12. |
| Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Knauer M, Moik M, Jakesz R, Seifert M, Taucher S, Bjelic-Radisic V, Balic M, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Selim U, Fitzal F, Hochreiner G, Wette V, Sevelda P, Ploner F, Bartsch R, Fesl C, Greil R |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Nov 17. pii: mdu544. doi: 10.1093/annonc/mdu544 |
| PMID: 25403582 |
| Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. |
| Bogner W, Pinker K, Zaric O, Baltzer P, Minarikova L, Porter D, Bago-Horvath Z, Dubsky P, Helbich TH, Trattnig S, Gruber S |
| Radiology. 2014 Oct 23. doi: 10.1148/radiol.14132340 |
| PMID: 25341078 |
| Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score. |
| Sestak I, Cuzick J, Dowsett M, Lopez-Knowles E, Filipits M, Dubsky P, Cowens JW, Ferree S, Schaper C, Fesl C, Gnant M |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Oct 20. pii: JCO.2014.55.6894. doi: 10.1200/JCO.2014.55.6894 |
| PMID: 25332252 |
| Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. |
| Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P |
| Breast (Edinburgh, Scotland). 2014 Jul 10. pii: S0960-9776(14)00124-6. doi: 10.1016/j.breast.2014.06.011 |
| PMID: 25017122 |
| The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer. |
| Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz R, Dubsky P |
| British journal of cancer. 2014 Jul 8. pii: bjc2014339. doi: 10.1038/bjc.2014.339. pmc: PMC4150264 |
| PMID: 25003667 |
| Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study. |
| Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Jul 2. pii: 1078-0432.CCR-13-2810. doi: 10.1158/1078-0432.CCR-13-2810 |
| PMID: 24963052 |
| Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial? |
| Knauer M, Filipits M, Dubsky P |
| Breast care (Basel, Switzerland). 2014 Jun 19. doi: 10.1159/000362482. pii: brc-0009-0097. pmc: PMC4038313 |
| PMID: 24944551 |
| The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer. |
| Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Feb 11. pii: 1078-0432.CCR-13-1845. doi: 10.1158/1078-0432.CCR-13-1845 |
| PMID: 24520097 |
| Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo Classification. |
| Panhofer P, Ferenc V, Schütz M, Gleiss A, Dubsky P, Jakesz R, Gnant M, Fitzal F |
| International journal of surgery (London, England). 2014 Jan 31. pii: S1743-9191(14)00020-X. doi: 10.1016/j.ijsu.2014.01.012 |
| PMID: 24486930 |
| Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). |
| Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt508. doi: 10.1093/annonc/mdt508 |
| PMID: 24347519 |
| 121 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
